Where each model wins on economics
Promise wholesale pricing can win when your clinic only orders Promise SKUs, your volume qualifies for tier discounts, and white-label patient packaging under one compounder is worth more than multi-partner batch checkout. The upside is a direct pharmacy relationship with in-house compounding, metro GLP-1 pages, and telehealth-oriented fulfillment. The risk is that wholesale rates are unverifiable during evaluation and ancillary fees may sit outside the headline per-vial number.
Pass-through pricing wins when a clinic needs to quote cash-pay patients on landed cost before the consult, batches dozens of GLP-1, hormone, or peptide refills across more than one 503A partner in one session, and wants validation before payment rather than one-patient-at-a-time portal ordering. Its limit is that it is an ordering and checkout layer — not a white-label compounding program — and it depends on assigned 503A partners rather than Promise-specific SKUs.